These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 6315843)

  • 21. Surveillance for hepatocellular carcinoma in patients with cirrhosis improves outcome.
    Stravitz RT; Heuman DM; Chand N; Sterling RK; Shiffman ML; Luketic VA; Sanyal AJ; Habib A; Mihas AA; Giles HC; Maluf DG; Cotterell AH; Posner MP; Fisher RA
    Am J Med; 2008 Feb; 121(2):119-26. PubMed ID: 18261500
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Urinary pseudouridine as a biochemical marker in the diagnosis and monitoring of primary hepatocellular carcinoma.
    Tamura S; Fujioka H; Nakano T; Amuro Y; Hada T; Nakao N; Higashino K
    Am J Gastroenterol; 1988 Aug; 83(8):841-5. PubMed ID: 2456010
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Magnetic resonance imaging of hepatocellular carcinoma mimicking focal nodular hyperplasia: a potential pitfall in patients with cirrhosis?
    Rafaelian O; Coakley FV; Qayyum A; Breiman RS; Yeh BM; Joe BN; Westphalen AC; Feng S
    J Comput Assist Tomogr; 2006; 30(5):796-9. PubMed ID: 16954932
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Serum selenium concentration in patients with liver cirrhosis and hepatocellular carcinoma.
    Buljevac M; Romić Z; Vucelić B; Banić M; Krznarić Z; Plesko S
    Acta Med Croatica; 1996; 50(1):11-4. PubMed ID: 8776109
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [The correlation of Child-Pugh score, PGA index and MELD score in the patient with liver cirrhosis and hepatocellular carcinoma according to the cause of alcohol and hepatitis B virus].
    Mun BS; Ahn HS; Ahn DS; Lee SO
    Taehan Kan Hakhoe Chi; 2003 Jun; 9(2):107-15. PubMed ID: 12824750
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Hepatic resection and transplantation for hepatocellular carcinoma in patients with cirrhosis].
    Gugenheim J; Baldini E; Casaccia M; Ouzan D; Saint-Paul MC; Mouiel J
    Gastroenterol Clin Biol; 1997; 21(8-9):590-5. PubMed ID: 9587497
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prognostic significance of three hepatitis markers (p53 antibodies, vascular endothelial growth factors and alpha fetoprotein) in patients with hepatocellular carcinoma.
    Gadelhak NA; Gadelhak SA; El-Morsi DA; Abdelaziz MM; Abbas AT; El-Emshaty HM
    Hepatogastroenterology; 2009; 56(94-95):1417-24. PubMed ID: 19950803
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Increased IGF-I : IGFBP-3 ratio in patients with hepatocellular carcinoma.
    Mattera D; Capuano G; Colao A; Pivonello R; Manguso F; Puzziello A; D'Agostino L
    Clin Endocrinol (Oxf); 2003 Dec; 59(6):699-706. PubMed ID: 14974910
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Diagnostic value of the copper/zinc ratio in hepatocellular carcinoma: a case control study.
    Poo JL; Rosas-Romero R; Montemayor AC; Isoard F; Uribe M
    J Gastroenterol; 2003; 38(1):45-51. PubMed ID: 12560921
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Indication of the extent of hepatectomy for hepatocellular carcinoma on cirrhosis by a simple algorithm based on preoperative variables.
    Cescon M; Cucchetti A; Grazi GL; Ferrero A; Viganò L; Ercolani G; Zanello M; Ravaioli M; Capussotti L; Pinna AD
    Arch Surg; 2009 Jan; 144(1):57-63; discussion 63. PubMed ID: 19153326
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A multidisciplinary approach to hepatocellular carcinoma in patients with cirrhosis.
    Schwartz ME; Sung M; Mor E; Fisher A; Popescu I; Fiel I; Sheiner P; Emre S; Guy S; Miller CM
    J Am Coll Surg; 1995 May; 180(5):596-603. PubMed ID: 7749537
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prospective study of alpha-fetoprotein in cirrhotic patients monitored for development of hepatocellular carcinoma.
    Oka H; Tamori A; Kuroki T; Kobayashi K; Yamamoto S
    Hepatology; 1994 Jan; 19(1):61-6. PubMed ID: 7506227
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sensitivity of commonly available screening tests in detecting hepatocellular carcinoma in cirrhotic patients undergoing liver transplantation.
    Gambarin-Gelwan M; Wolf DC; Shapiro R; Schwartz ME; Min AD
    Am J Gastroenterol; 2000 Jun; 95(6):1535-8. PubMed ID: 10894592
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Radiofrequency ablation of hepatocellular carcinoma in patients with cirrhosis].
    Bonny C; Abergel A; Gayard P; Chouzet S; Ughetto S; Slim K; Rosenfeld L; Guillon R; Poincloux L; Bommelaer G
    Gastroenterol Clin Biol; 2002; 26(8-9):735-41. PubMed ID: 12434078
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prognostic factors of hepatic resection for hepatocellular carcinoma with cirrhosis: univariate and multivariate analysis.
    Yeh CN; Chen MF; Lee WC; Jeng LB
    J Surg Oncol; 2002 Dec; 81(4):195-202. PubMed ID: 12451624
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Focus on a new assay of fucosylated alpha-fetoprotein and evaluation in the biological diagnosis of hepatocellular carcinoma in cirrhosis].
    Denis I; Beaudonnet A; Pichot J; Roubille M; Gelineau M
    Ann Biol Clin (Paris); 2000; 58(1):85-90. PubMed ID: 10673618
    [No Abstract]   [Full Text] [Related]  

  • 37. Hepatic resection for hepatocellular carcinoma in diameter of > or = 10 cm.
    Hanazaki K; Kajikawa S; Shimozawa N; Shimada K; Hiraguri M; Koide N; Adachi W; Amano J
    Hepatogastroenterology; 2002; 49(44):518-23. PubMed ID: 11995486
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Colchicine delays the development of hepatocellular carcinoma in patients with hepatitis virus-related liver cirrhosis.
    Arrieta O; Rodriguez-Diaz JL; Rosas-Camargo V; Morales-Espinosa D; Ponce de Leon S; Kershenobich D; Leon-Rodriguez E
    Cancer; 2006 Oct; 107(8):1852-8. PubMed ID: 16967451
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long-term results of hepatic resection for hepatocellular carcinoma originating from the noncirrhotic liver.
    Chang CH; Chau GY; Lui WY; Tsay SH; King KL; Wu CW
    Arch Surg; 2004 Mar; 139(3):320-5; discussion 326. PubMed ID: 15006892
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Diagnostic value of serum copper, zinc and plasma fibrinogen in cirrhotic patients with and without hepatocellular carcinoma.
    Doğan UB; Cindoruk M; Dumlu S; Unlü R; Unal S
    Ital J Gastroenterol Hepatol; 1997 Oct; 29(5):476-7. PubMed ID: 9494860
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.